BluePill, the AI platform building 'AI consumers' to replace traditional market research, announced it has raised $6 million in seed funding led by Ubiquity Ventures, with participation from Pioneer Square Labs and Flying Fish Ventures.

BluePill solves a fundamental challenge: knowing which new product will succeed, which campaign will perform, and which packaging or activation will drive engagement. It replaces expensive, weeks-long studies by accurately simulating how thousands of 'digital-twin' AI consumers react to new products, campaigns, and ideas in minutes. All insights are continuously benchmarked against live human panels, with humans in the loop to ensure accuracy.